109227 ⎘
Applications; Uses Methods for regulating/modulating their activity
Intelligent nanomedicine integrating diagnosis and therapy
#302Multitargeting interfering RNAs having two active strands and methods for their design and use
#303Small internally segmented interfering RNA
#304Methods and compositions involving miRNA and miRNA inhibitor molecules
#305Cosmetic designs and products using intronic RNA
#306Modular polynucleotides for ligand-controlled regulatory systems
#307Methods and compositions for silencing genes without inducing toxicity
#308Splicing-Mediated Regulation Of Gene Expression
#309Inducible SIRNA expression cassette and method of use
#310Methods and compositions for controlling efficacy of RNA silencing
#311Modulating Gene Expression with agRNA and Gapmers Targeting Antisense Transcripts
#312Sequence-specific inhibition of small RNA function
#313Methods for producing microRNAs
#314Compositions and Methods for Regulating Gene Expression
#315GENE SILENCING BY SYSTEMIC RNA INTERFERENCE
#316Plant microRNAs and methods of use thereof
#317METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
#318RNAi Medicine Having No Adverse Effects
#319Compositions and methods for studying and treating inflammatory diseases and disorders
#320SHRNA AND SIRNA AND MIRNA EXPRESSION IN A LIVING ORGANISM UNDER CONTROL OF A CODON-OPTIMIZED REPRESSOR GENE
#321Double-Stranded Oligonucleotides
#322Crosslinking agent, crosslinking method, method of controlling gene expression, and method of examining gene function
#323Orthotopic, controllable, and genetically tractable non-human animal model for cancer
#324METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA
#325MODIFICATION OF DOUBLE-STRANDED RIBONUCLEIC ACID MOLECULES
#326Methods and compositions for controlling efficacy of RNA silencing
#327Treatment of Cancer Using Tlr3 Agonists
#328Tetracycline-Dependent Regulation of Rna Interference
#329Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial
#330Multiple shRNA Expression Vectors and Methods of Construction
#331Structures of Active Guide Rna Molecules and Method of Selection
#332Target-dependent nucleic acid adapter
#333TREATMENT OF CANCER USING TLR3 AGONISTS
#334Methods of altering an immune response induced by CpG oligodeoxynucleotides
#335Methods and compositions for reducing viral genome amounts in a target cell
#336Inhibitor Nucleic Acids
#337Photocleavable oligonucleotide and uses thereof
#338Oligonucleotide probes useful for detection and analysis of microRNA precursors
#339Triggered RNAi
#340Antibacterial antisense oligonucleotide and method
#341Methods and compositions involving miRNA and miRNA inhibitor molecules
#342Methods and compositions involving miRNA and miRNA inhibitor molecules
#343Positionally modified siRNA constructs
#344Compositions and Methods That Enhance Rna Interference
#345RECOMBINANT EUKARYOTIC CELLS STABLY EXPRESSING (SID-1) PROTEINS FOR HIGH THROUGHPUT GENE SCREENING
#346Methods of using combinations of siRNAs for treating a disease or a disorder, and for enhancing siRNA efficacy in RNAi
#347Methods and compositions involving miRNA and miRNA inhibitor molecules
#348Methods, libraries and computer program products for determining whether siRNA induced phenotypes are due to off-target effects
#349Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial
#350Multitargeting interfering RNAs having two active strands and methods for their design and use
#351Compositions and methods for enhancing discriminatory RNA interference
#352COMPOSITIONS AND METHODS EMPLOYING UNIVERSAL-BINDING NUCLEOTIDES FOR TARGETING MULTIPLE GENE VARIANTS WITH A SINGLE siRNA DUPLEX
#353Compositions and methods for altering RNAi
#354Methods, libraries and computer program products for gene silencing with reduced off-target effects
#355Antisense antibacterial method and compound
#356Modulation of gene expression by oligomers targeted to chromosomal DNA
#357Methods for producing microRNAs
#358Oligonucleotide N3'-P5' thiophosphoramidates: their synthesis and use
#359ES cells having enhanced RNAi effect
#360Methods and compositions for silencing genes without inducing toxicity
#361Dual functional oligonucleotides for use as anti-viral agents
#362Mule: Mcl-1 ubiquitination ligase E3
#363Oligomeric compounds and compositions for use in modulation of pri-mirnas
#364Molecular method to augment RNA mediated gene silencing
#365Lipophilic derivatives of double-stranded ribonucleic acid
#366Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended siRNA
#367Treatment of cancer using TLR3 agonists
#368Regulated aptamer therapeutics
#369Enhanced antisense oligonucleotides
#370Cell specific gene silencing using cell-specific promoters in vitro and in vivo
#371Controlled modulation of the pharmacokinetics and biodistribution of aptamer therapeutics
#372Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMA
#373Double-stranded oligonucleotides
#374Control of gene expression via light activated RNA interference
#375Cre-lox based method for conditional RNA interference
#376Methods and compositions for reducing viral genome amounts in a target cell
#377RNA interference compositions and screening methods for the identification of novel genes and biological pathways
#378Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
#379Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#380Compositions and methods that modulate RNA interference
#381Inhibitor nucleic acids
#382Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
#383Sequence-specific inhibition of small RNA function
#384Manipulation of RNA interference through modulation of armitage activity
#385Methods and compositions for enhancing the efficacy and specificity of RNAi
#386Virally-encoded RNAs as substrates, inhibitors and delivery vehicles for RNAi
#387Enhancement of RNAi activity through mutation
#388Regulatable promoters for synthesis of small hairpin RNA
#389Oligomeric compounds having modified bases for binding to adenine and guanine and their use in gene modulation
#390Delivery of dsRNA to arthropods
#391Treating cancer using an oligonucleotide N3′->N5′ thiophosphoramidate
#392Methods and compositions for controlling efficacy of RNA silencing
#393Modulation of the RNA interference pathway
#394Oligomeric compounds having modified bases for binding to adenine and guanine and their use in gene modulation
#395Compositions and systems for the regulation of genes
#396ES cells having enhanced RNAi effect
#39717β-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof